Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study

References

• CelanoCMHuffmanJCDepression and cardiac disease: a reviewCardiol Rev20111913014221464641
   PubMed Web of Science ®Google Scholar
• LesperanceFFrasure-SmithNDepression in patients with cardiac disease: a practical reviewJ Psychosom Res20004837939110880660
   PubMed Web of Science ®Google Scholar
• DowlatiYHerrmannNSwardfagerWLReimEKLanctotKLEfficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysisCan J Psychiatry201055919920181304
   PubMed Web of Science ®Google Scholar
• BlumenthalJASherwoodABabyakMAExercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) studyJ Am Coll Cardiol2012161053106322858387
   PubMed Web of Science ®Google Scholar
• StapelbergNJCNeumannDLShumDHKMcConnellHHamilton-CraigIA topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart diseaseAust NZ J Psychiatry201145351369
   PubMed Web of Science ®Google Scholar
• BauneBTStuartMGilmourAThe relationship between subtypes of depression and cardiovascular disease: a systematic review of biological modelsTransl Psychiatry201213e9222832857
   PubMed Web of Science ®Google Scholar
• MoylanSMaesMWrayNRBerkMThe neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implicationsMol Psychiatry201318559560622525486
   PubMed Web of Science ®Google Scholar
• KueblerWMYangYSamapatiRUhligSVascular barrier regulation by PAF, ceramide, caveolae, and NO – an intricate signaling network with discrepant effects in the pulmonary and systemic vasculatureCell Physiol Biochem201026294020502002
   PubMedGoogle Scholar
• AraiALynchGAntagonists of the platelet-activating factor receptor block long-term potentiation in hippocampal slicesEur J Neurosci1992441141912106349
   PubMed Web of Science ®Google Scholar
• ChenHZhengPZhuHPlatelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart diseaseClin Oral Investig201014629636
   Web of Science ®Google Scholar
• WinklerKWinkelmannBRScharnaglHPlatelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health StudyCirculation2005111980987 Erratum in Circulation. 2005;111(24):e44415710755
   PubMed Web of Science ®Google Scholar
• SamsamshariatSBasatiGMovahedianAPourfarzamMSarrafzadeganNElevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery diseaseJ Res Med Sci20111667467922091291
   PubMed Web of Science ®Google Scholar
• WilenskyRLMacpheeCHLipoprotein-associated phospholipase A(2) and atherosclerosisCurr Opin Lipidol20092041542019667981
   PubMed Web of Science ®Google Scholar
• WinklerKHoffmannMMWinkelmannBRLipoprotein-associated phospholipase A2 predicts 5-year cardiac mortality independently of established risk factors and adds prognostic information in patients with low and medium high-sensitivity C-reactive protein (the Ludwigshafen risk and cardiovascular health study)Clin Chem2007531440144717573419
   PubMed Web of Science ®Google Scholar
• KlabundeREAndersonDERole of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakageJ Vasc Res20023923824512097822
   PubMed Web of Science ®Google Scholar
• FarooquiAAHorrocksLAFarooquiTModulation of inflammation in brain: a matter of fatJ Neurochem200710157759917257165
   PubMed Web of Science ®Google Scholar
• MazereeuwGHerrmannNBennettSALPlatelet activating factors in depression and coronary artery disease: A potential biomarker related to inflammatory mechanisms and neurodegenerationNeurosci Biobehav Rev2013371611162123800745
   PubMed Web of Science ®Google Scholar
• MolloyDWStandardized Mini Mental State ExaminationTroy, ON, CanadaNew Grange Press1999
   Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• StrikJJHonigALousbergRDenolletJSensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarctionPsychosomatics20014242342811739910
   PubMed Web of Science ®Google Scholar
• FirstMBSpitzerRLGibbonMStructured clinical interview for DSM-IV diagnoses (SCID): Clinician and research versionsNew York, NYBiometrics Research Department, Columbia University1996
   Google Scholar
• MazereeuwGHerrmannNXuHPlatelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating studyJ Neuroinflammation20141111924996486
   PubMed Web of Science ®Google Scholar
• WhiteheadSNHouWEthierMIdentification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometryAnal Chem2007798539854817949058
   PubMed Web of Science ®Google Scholar
• RyanSDWhiteheadSNSwayneLAAmyloid-β42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolismProc Natl Acad Sci U S A2009106209362094119926863
   PubMed Web of Science ®Google Scholar
• BlanchardAPMcDowellGSVValenzuelaNVisualization and Phospholipid Identification (VaLID): online integrated search engine capable of identifying and visualizing glycerophospholipids with given massBioinformatics20132928428523162086
   PubMed Web of Science ®Google Scholar
• DowlatiYHerrmannNSwardfagerWRelationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery diseaseNeuropsychiatr Dis Treat2010739340020856603
   PubMed Web of Science ®Google Scholar
• TodaroJFShenB-JNiauraRTilkemeierPLPrevalence of depressive disorders in men and women enrolled in cardiac rehabilitationJ Cardiopulm Rehabil2005257175 quiz 76–7715818192
   PubMedGoogle Scholar
• MadjidMAwanIWillersonJTCasscellsSWLeukocyte count and coronary heart disease: implications for risk assessmentJ Am Coll Cardiol2004441945195615542275
   PubMed Web of Science ®Google Scholar
• DemirkanAIsaacsAUgocsaiPPlasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics studyJ Psychiatr Res20134735736223207112
   PubMed Web of Science ®Google Scholar
• FariaRSantanaMMAveleiraCAAlterations in phospholipidomic profile in the brain of mouse model of depression induced by chronic unpredictable stressNeuroscience201427311124814727
   PubMed Web of Science ®Google Scholar
• RyanSDHarrisCSCarswellCLBaenzigerJEBennettSALHeterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neuronsJ Lipid Res2008492250225818550892
   PubMed Web of Science ®Google Scholar
• GroenewoldNADoornbosBZuidersmaMComparing cognitive and somatic symptoms of depression in myocardial infarction patients and depressed patients in primary and mental health carePLoS One20138e5385923342019
   PubMed Web of Science ®Google Scholar
• KettererMWMahrGGoldbergADPsychological factors affecting a medical condition: ischemic coronary heart diseaseJ Psychosom Res20004835736710880658
   PubMed Web of Science ®Google Scholar
• SatoSYehTLChallenges in treating patients with major depressive disorder: the impact of biological and social factorsCNS Drugs201327Suppl 1S5S1023712795
   PubMed Web of Science ®Google Scholar
• MaesMRuckoanichPChangYSMahanondaNBerkMMultiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patientsProg Neuro-Psychopharmacol Biol Psychiatry201135769783
   PubMed Web of Science ®Google Scholar
• FahyECotterDSudMSubramaniamSLipid classification, structures and toolsBiochim Biophys Acta2011181163764721704189
   PubMed Web of Science ®Google Scholar